The global stool secretory immunoglobulin A (SIgA) market was valued at ~US$ 27 Mn in 2022. It is anticipated to expand at a CAGR of ~3% from 2022 to 2030.
The global stool secretory immunoglobulin A (SIgA) market was valued at ~US$ 27 Mn in 2022. It is anticipated to expand at a CAGR of ~3% from 2022 to 2030.
Research and Development Activities to Open Up New Avenues
The global stool secretory immunoglobulin A (SIgA) market is expected to be driven by consistent rise in the diagnosis of selective IgA deficiencies in suspected cases due to chronic infection. The notable surge in the overall awareness pertaining to recurrent infection is another critical driver of the stool secretory immunoglobulin A (SIgA) market. At present, researchers are increasingly focusing on assessing the targets of immunoglobulin (Ig) A in comparison with IgG responses due to which, the growth of the stool secretory immunoglobulin A (SIgA) market is expected to remain steady during the forecast period.
Download Sample @ https://qyresearchmedical.com/sample/111577
Advancements in technology have enabled researchers to offer insights pertaining to gastrointestinal micro biota composition and its link with the host. Advancements in stool secretory immunoglobulin A (SIgA) continue to highlight the interaction between the host and micro biome due to which, the global stool secretory immunoglobulin A (SIgA) market is expected to grow at a steady pace. A notable rise in the adoption of preventive care for a healthier lifestyle is a major factor that is likely to propel the market for stool secretory immunoglobulin A (SIgA) during the assessment period.
At the back of these factors, the global stool secretory immunoglobulin A (SIgA) market is on course to reach US$ 38 Mn by the end of 2030.
Critical Role in Mucosal Homeostasis to Accelerate Market Growth
Immunoglobulin A (IgA) is one of the key immunoglobulins and plays a critical role in the mucosal homeostasis in respiratory, genitourinary, and gastrointestinal tracts. Moreover, it also provides optimum protection against antigens due to which, the stool secretory immunoglobulin A (SIgA) market is staring at a bright future. Selective IgA deficiency is a common and prevalent immunodeficiency among humans due to which, additional research is being carried out in the global stool secretory immunoglobulin A (SIgA) market to address this issue. The increasing demand for stool secretory immunoglobulin A (SIgA) to treat recurrent sino-pulmonary infections is another major factor that would propel the market. Furthermore, as IgA plays a key role in the body as an anti-inflammatory due to which, autoimmune conditions and allergic diseases occur. In addition, reduction in stool secretory immunoglobulin A (SIgA) leads to a weaker mucosal barrier and enables allergens to enter the bloodstream– an area that has attracted considerable attention from researchers.
Rise in Adoption in Diagnostic Centers and Labs to Bolster Market Growth
Hospitals, diagnostic centers, and labs are the most prominent end users within the global stool secretory immunoglobulin A (SIgA) market and the trend is expected to continue during the forecast period. A noteworthy amount of stool secretory immunoglobulin A tests are carried out at standalone and hospital-based diagnostic laboratories in several regions of the world, particularly in developed regions, including North America and Europe. A number of top tier market players involved in the current stool secretory immunoglobulin A (SIgA) market landscape are largely based in North America due to which, the region is expected to remain at the forefront in terms of market growth and share.
Market Growth Likely to Remain Steady amid COVID-19 Pandemic
The advent of the COVID-19 pandemic is expected to have a moderate impact on the overall growth of the global stool secretory immunoglobulin A (SIgA) market in 2020. Research and development activities are likely to continue in full swing, as governments in all the nations have given the green light to research and development activities pertaining to the healthcare sector. Although the primary focus of governments in several nations is projected to remain on curbing the transmission of the novel COVID-19 infection, the growth of the stool secretory immunoglobulin A (SIgA) market is expected to remain steady amid the COVID-19 pandemic.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Stool Secretory Immunoglobulin A [SIgA] Market
Analysts’ Viewpoint
The global stool secretory immunoglobulin A (SIgA) market is expected to expand at a moderate CAGR of ~3% during the forecast period. The market growth is primarily driven by advancements in technology, research and development activities, and significant rise in healthcare expenditure worldwide. Market players should focus on research and continue to eye collaboration opportunities with researchers to gain a competitive edge.
Stool Secretory Immunoglobulin A (SIgA) Market: Overview
The global stool secretory immunoglobulin A (SIgA) market for the historical period 2018–2019 and forecast period 2020–2030, the global stool secretory immunoglobulin A (SIgA) market is driven by the rise in the diagnosis of selective IgA deficiency in suspected cases due to chronic infection
Increase in Awareness Regarding Recurrent Infection: Key Driver of Stool Secretory Immunoglobulin A (SIgA) Market
Rise in the adoption of preventive care for healthy lifestyle, diagnosis of selective IgA deficiency in suspected cases due to of chronic or recurrent infections, autoimmune diseases, chronic diarrhea, and benefits offered by secretory immunoglobulin A (SIgA) diagnostics are expected to propel the market during the forecast period
Increase in recurrent respiratory tract infections, gastric infections, and rise in occurrence of autoimmune diseases in North America and Europe is projected to drive the secretory immunoglobulin A (SIgA) diagnostics market
Pricing Pressure: Key Restraint of Stool Secretory Immunoglobulin A (SIgA) Market
Product offering at relatively lower than average selling price has increased market penetration of local players having wide distribution network in certain geographies
This is imposing pricing pressure on major manufacturers, thereby intensifying competition. Dominance of local players offering a wide range of reagents portfolio at lower rates is hampering the geographic expansion of major players in particular regions. This is likely to act as a deterrent for manufacturers to expand their SigA test portfolio.
Mergers, Acquisitions, and Strategic Partnerships: Key Opportunities
Trend of mergers, acquisitions, and strategic partnerships in the life science industry has been observed over the past few years. These acquisitions and partnerships are primarily aimed at strengthening the company’s diagnostics test offering in various medical specialties, development of new products/tests, and to increase geographic presence.
For instance, in April 2017, ERBA Diagnostics Mannheim acquired Calbiotech Inc, a U.S.-based specialist in immunoassay development and manufacturing; Calbiotech Veterinary Diagnostics Inc, and Moduline Systems Inc
Stool Secretory Immunoglobulin A (SIgA) Market: Competition Landscape
This report profiles major players in the global stool secretory immunoglobulin A (SIgA) market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global stool secretory immunoglobulin A (SIgA) market is highly fragmented, owing to the presence of numerous international as well as regional players
Leading players operating in the global stool secretory immunoglobulin A (SIgA) market include
- BioVendor Group
- Sigma Diagnostics Inc.
- American Laboratory Products Company
- Calbiotech, Inc.
- Eagle Biosciences
- R-Biopharm AG
- Tecan Trading AG
Stool Secretory Immunoglobulin A (SIgA) Market: Key Developments
Key players in the global stool secretory immunoglobulin A (SIgA) market are engaged in regulatory approvals, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to augment the global stool secretory immunoglobulin A (SIgA) market. A few expansion strategies adopted by players operating in the global stool secretory immunoglobulin A (SIgA) market are:
In April 2019, StressMarq signed a distribution agreement with Eagle Biosciences Inc. for the distribution of its products in the U.S.
The report on the global stool secretory immunoglobulin A (SIgA) market discusses individual strategies, followed by company profiles of manufacturers and suppliers of stool secretory immunoglobulin A (SIgA). The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global stool secretory immunoglobulin A (SIgA) market.
Key Questions Answered in Stool Secretory Immunoglobulin A (SIgA) Market Report
- What is the scope of growth of product companies in the global stool secretory immunoglobulin A (SIgA) market?
- What will be the Y-o-Y growth of the global stool secretory immunoglobulin A (SIgA) market between 2020 and 2030?
- What is the influence of changing trends in life science research on the global stool secretory immunoglobulin A (SIgA) market?
- Will North America continue to be the most profitable market for stool secretory immunoglobulin A (SIgA) providers?
- Which factors are anticipated to hamper the growth of the global stool secretory immunoglobulin A (SIgA) market during the forecast period?
- Which are the leading companies in the global stool secretory immunoglobulin A (SIgA) market?
Stool Secretory Immunoglobulin A (SIgA) Market – Segmentation
Use
- Testing
- Allergic Disease
- Infection
- GI Inflammation
- Autoimmune Disease
- Research
End User
- Hospitals
- Labs and Diagnostic Centers
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111577/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/